PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
PacBio (NASDAQ: PACB) will report fourth quarter and full year 2025 financial results on Thursday, February 12, 2026.
Rhea-AI Summary
PacBio (NASDAQ: PACB) will report fourth quarter and full year 2025 financial results on Thursday, February 12, 2026. A quarterly conference call and webcast will be held at 5:00 PM Eastern Time (2:00 PM Pacific) and will be accessible via PacBio's investor website.
Investors can listen live via the webcast or by phone: toll-free 1-888-349-0136 or international 1-412-317-0459. A replay will be available on the investor site after the call.
Positive
- None.
Negative
- None.
Details
News Market Reaction – PACB
In the Jan 28 session, PACB declined 7.39%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings call date
- February 12, 2026
- Scheduled fourth quarter and full year 2025 results discussion
- Earnings call time ET
- 5:00 pm ET
- Scheduled start time of conference call
- Earnings call time PT
- 2:00 pm PT
- Pacific Time equivalent for the call
- Toll-free dial-in
- 1-888-349-0136
- Domestic investor conference call access
- International dial-in
- 1-412-317-0459
- International investor conference call access
Historical Context
-
Collaboration to apply HiFi long-read sequencing to ultra-rare genetic diseases.
-
HiFi whole-genome sequencing adopted as first-line approach for SUDC study.
-
Preliminary Q4 and 2025 revenue update with growth and cash balance detail.
-
Introduction of CiFi long-read 3C method enabling chromosome-scale assemblies.
-
Announcement of presentation at the 44th Annual J.P. Morgan Healthcare Conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, at 5:00 pm Eastern Time.
The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/.
Date: Thursday, February 12, 2026, at 5:00 pm ET (2:00 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Jim Gibson
ir@pacb.com
Media:
pr@pacb.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.